NCT04801498

Brief Summary

This pilot study is being performed to examine whether epidermal axons are altered in patients taking opioid therapy for chronic non-cancer pain, and if epidermal axonal changes predict heightened pain sensitivity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 7, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 11, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 17, 2021

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 25, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 25, 2024

Completed
Last Updated

November 6, 2024

Status Verified

November 1, 2024

Enrollment Period

3.6 years

First QC Date

March 11, 2021

Last Update Submit

November 4, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • IENFD

    Intraepidermal Nerve Fiber Density

    Baseline

Secondary Outcomes (16)

  • Fibromyalgianess

    Baseline

  • Clinical Pain Severity

    Baseline

  • Neuropathic Pain Descriptors

    Baseline

  • Stress

    Baseline

  • Catastrophizing

    Baseline

  • +11 more secondary outcomes

Study Arms (3)

Healthy controls

Men and women ages 18-65 years old with no major medical problems and no history of chronic pain or opioid use.

Chronic pain patients not taking opioids

Diagnosis of non-cancer chronic pain syndrome (persistent pain lasting longer than 3 months) that have not used any opioid medication within the past one year.

Chronic pain patients taking opioids

Diagnosis of non-cancer chronic pain syndrome (persistent pain lasting longer than 3 months) using chronic daily opioid use for longer than 3 months duration and taking stable doses of opioid medications for at least 30 days prior to study visit.

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

A cross-sectional study will recruit a total of 60 men and women in three cohorts (20 each): 1) chronic non-cancer pain patients who are utilizing long-term (greater than 3 months of daily use) opioid medication to treat their chronic pain conditions, 2) chronic non-cancer pain patients who do not take opioid medications, and 3) healthy controls.

You may qualify if:

  • Healthy/All:
  • Informed consent provided by the participant
  • Able to read and speak in English
  • Age 18 to 65 years
  • Likely to participate in all scheduled evaluations and study procedures
  • IF they are a Chronic Non-Cancer Patients who do NOT take opioid medication they must meet all of the above criteria as well as:
  • Diagnosis of non-cancer chronic pain syndrome (persistent pain lasting longer than 3 months)
  • IF they are a Chronic Non-Cancer Patients who DO take opioid medication they must meet all of the above criteria as well as:
  • Chronic daily opioid use for longer than 3 months duration
  • Stable doses of opioid medications for at least 30 days prior to study visit

You may not qualify if:

  • Pregnancy
  • Prisoner
  • Current clinically significant cardiac, or neurologic disease
  • Significant skin disorders in lower extremities
  • Circulatory insufficiency
  • Open wounds in lower extremity that may interfere with healing
  • Lidocaine allergy
  • Currently taking anticoagulation (e.g., Coumadin, Plavix, etc)
  • Current litigation for chronic pain
  • Active psychotic or suicidal symptoms
  • Current drug or alcohol abuse
  • Neuropathy in upper extremities (hands specifically, PI discretion).
  • Current or recent use of artificial fingernails or nail enhancements (last 6 months)
  • Other diagnoses that are not considered minor/stable (PI discretion)
  • Current or previous cancer diagnosis
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kansas Health System

Kansas City, Kansas, 66160, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

Cheek swab

MeSH Terms

Conditions

Chronic Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Andrea L Chadwick, MD, MSc, FASA

    University of Kansas School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 11, 2021

First Posted

March 17, 2021

Study Start

December 7, 2020

Primary Completion

June 25, 2024

Study Completion

June 25, 2024

Last Updated

November 6, 2024

Record last verified: 2024-11

Locations